ArticleCrohn's & colitis 3602021

The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY Study.

Gerassimos J Mantzaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.